MedPath

Prospective interventional study assessing the effectiveness on ameliorating surgical stress and the enhancement of recovery after surgery by Miyagi Cancer Center Head and Neck ERAS Protocol (MCC-HN ERAS)

Not Applicable
Conditions
Head and Neck Cancers
Registration Number
JPRN-UMIN000030467
Lead Sponsor
Miyagi Cancer Center
Brief Summary

The duration of hospital stay: Median 25 days. The duration until completion of the discharge criteria: Median 17 days. Early mobilization: 86.0% (POD1), 96.5% (POD2). Enteral nutrition: 80.1% (POD1), 100% (POD2). Postoperative pain: Mean VAS scores of 1.51 to 3.13. Clavien Dindo grade II or higher postoperative complications: 27.6% of the patients. The mean QOR40 score: 179.6 preoperatively, 146.1 at POD3, and 167.8 at POD7.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with hypersensitivity to dexamethasone. 2) Patients with active infectious diseases such as tuberculosis, viral infection and mycosis. 3) Patients with thrombosis. 4) Patients with poor-controlled diabetes mellitus; e.g. insulin dependent. 5) Patients with uncontrolled psycogenic disease, such as depression. 6) Patients with active peptic ulcer. 7) Patients with uncontrolled glaucoma. 8) Patients with regular use of oral steroid for such conditions as autoimmune disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Postoperative period to discharge. 2)Postoperative period to the day meeting the discharge criteria.
Secondary Outcome Measures
NameTimeMethod
1) Postoperative patients' satisfaction rating (QoR-40 score) 2) Inflammatory response as surgical invasiveness 3) Pain control 4) Postoperative nausea and vomiting 5) Postoperative period until the commencement of enteral nutrition 6) Nutritional intake independence 7) Daily activities independence 8) Water balance 9) Organ disorder 10) Postoperative complication 11) Protocol compliance rate
© Copyright 2025. All Rights Reserved by MedPath